NNK
| Names | |
|---|---|
| Preferred IUPAC name
Methyl[4-oxo-4-(pyridin-3-yl)butyl]nitrous amide | |
| Other names
N-Nitrosonornicotine ketone; 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone | |
| Identifiers | |
3D model (JSmol) |
|
| 3548355 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.164.147 |
| KEGG | |
PubChem CID |
|
| UNII | |
| UN number | 2811 |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C10H13N3O2 | |
| Molar mass | 207.233 g·mol−1 |
| Hazards | |
| GHS labelling: | |
| Danger | |
| H301, H302, H317, H351 | |
| P201, P202, P261, P264, P270, P272, P280, P281, P301+P310, P301+P312, P302+P352, P308+P313, P321, P330, P333+P313, P363, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Nicotine-derived nitrosamine ketone (NNK) is one of the key tobacco-specific nitrosamines (TSNAs) derived from nicotine. It plays an important role in carcinogenesis. The conversion of nicotine to NNK entails opening of the pyrrolidine ring.